Construction of a Dual-Mode Biosensor with Ferrocene as Both a Signal Enhancer and a Signal Tracer for Electrochemiluminescent and Electrochemical Enantioselective Recognition

Chenyu Zhu, Maoding Zuo, Yuncong Yang, Ning-ning Zhao, Xiaolei Wang, Lin Cui, Chun‐yang Zhang

Analytical Chemistry · 2023 · 26 citations · 48 references

Abstract

We demonstrate for the first time the construction of a dual-mode biosensor for electrochemiluminescent (ECL) and electrochemical chiral recognition of l- and d-isomers of amino acids, with ferrocene (Fc) as both a signal enhancer and a signal tracer. With the dissolved oxygen as a coreactant, ZnIn<sub>2</sub>S<sub>4</sub> acts as the ECL emitter to generate a weak cathodic ECL signal. Fc can enter into the β-cyclodextrin (β-CD) cavity on ZnIn<sub>2</sub>S<sub>4</sub>-modified electrode as a result of host-guest interaction. Since Fc can promote H<sub>2</sub>O and O<sub>2</sub> to produce abundant reactive oxygen species (ROS) (e.g., O<sub>2</sub><sup>·</sup><sup>-</sup> and <sup>·</sup>OH), the ECL signal of ZnIn<sub>2</sub>S<sub>4</sub> can be further amplified with Fc as a coreaction accelerator. Meanwhile, Fc molecules on the β-CD/ZnIn<sub>2</sub>S<sub>4</sub>-modified electrode can be electrochemically oxidized to Fc<sup>+</sup> to produce a remarkable oxidation peak current. When l-histidine (l-His) is present, the matching of the l-His configuration with the β-CD cavity leads to the entrance of more l-His into the cavity of β-CD than d-histidine (d-His), and the subsequent competence of l-His with Fc on the Fc/β-CD/ZnIn<sub>2</sub>S<sub>4</sub>-modified electrode induces the decrease in both Fc peak current and ZnIn<sub>2</sub>S<sub>4</sub>-induced ECL intensity. This dual-mode biosensor can efficiently discriminate l-His from d-His, and it can sensitively monitor l-His with a detection limit of 7.60 pM for ECL mode and 3.70 pM for electrochemical mode. Moreover, this dual-mode biosensor can selectively discriminate l-His from other l- and d-isomers (e.g., threonine, phenylalanine, and glutamic acid), with potential applications in the chiral recognition of nonelectroactive chiral compounds, bioanalysis, and disease diagnosis.

References

48